本条目为第三方公开资料的归档，仅用于学术研究与科普，不构成任何操作指导或医学建议；物质处理涉及法律与健康风险，请在专业、合法的条件下自行核验。
正文中文为机器翻译，仅供参考；专业内容以折叠的原文为准。
- 详情
- 别名
- 1pethlad
- 分类
- 致幻剂 tentative research-chemical
- 剂量说明
NOTE: These doses are very tentative, and are based on the likelihood that the dosage profile will be similar to ETH-LAD.
- 后遗时间
- 2-12 小时
- 剂量
- 口服
- 常规
- 60-100ug
- 轻度
- 30-60ug
- 强效
- 100-200ug+
- 阈值
- 20-30ug
- 持续时间
- 6-10 小时
- 起效时间
- 15-90 分钟
- 名称
- 1p-eth-lad
- 通用名
- 1P-ETH-LAD
- 属性
- 后遗效应
- 2–12 小时.
- 别名
- 1pethlad
- 分类
- 致幻剂 tentative research-chemical
- 剂量
- Oral Threshold: 20-30ug Light: 30-60ug Common: 60-100ug Strong: 100-200ug+ | NOTE: These doses are very tentative, and are based on the likelihood that the dosage profile will be similar to ETH-LAD.
- 持续
- 6–10 小时.
- 经验报告
- https://erowid.org/experiences/subs/exp_1PETHLAD.shtml
- 起效
- 15–90 分钟
- 摘要
A new psychedelic lysergamide which is suspected to be a prodrug of ETH-LAD, which could explain why the doses are very similar, it alternatively could be active on its own. There are no studies on it currently.
来源与许可
TripSit · 药物资料
TripSit 数据规则：仅限非商业使用，需署名并在每个展示页附来源链接；组合数据仅为快速参考，需结合个体研究判断。
Reference snapshot, not a forum post. Source: TripSit. Noncommercial reuse with TripSit attribution and a source link on every display page; combination data is a quick reference requiring further individual research. https://wiki.tripsit.me/wiki/Factsheets ; https://wiki.tripsit.me/wiki/Drug_combinations . The package.json ISC software tag does not replace these data-specific terms.
Raw source: https://raw.githubusercontent.com/TripSit/drugs/83670cb6bc8863615fcb9be081c87f061b42dea4/drugs.json
Fetched at: 2026-10-23T07:01:06.728397+00:00
Record key: drug:1p-eth-lad
来源主页：https://wiki.tripsit.me/wiki/Factsheets
组合说明：https://wiki.tripsit.me/wiki/Drug_combinations